 |
|
Targeting eosinophils: another strategy for asthma treatment
Hye Mi Jee
Clin Exp Pediatr. 2021;64(5):223-224. Published online 2021 Mar 5 DOI: https://doi.org/10.3345/cep.2021.00017
|
|
Citations to this article as recorded by
 Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)
H. James Wedner, Takao Fujisawa, Theresa W. Guilbert, Masanori Ikeda, Vinay Mehta, Jonathan S. Tam, Pradeep B. Lukka, Sara Asimus, Tomasz Durżyński, James Johnston, Wendy I. White, Mihir Shah, Viktoria Werkström, Maria L. Jison
Pediatric Allergy and Immunology.2024;[Epub] CrossRef
|